Author:
Janz Dieter,Schmidt Dieter
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference19 articles.
1. Arnold, K., Gerber, N.: The rate of decline of diphenylhydantoin in human plasma. Clin. Pharmacol. Ther.11, 121?134 (1970)
2. Berlin, A., Agurell, S., Borga, O., Lund, L., Sjöqvist, F.: Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid ? a comparison between a gas chromatographic and a spectrophotometric method. Scand. J. clin. Lab. Invest.29, 281?287 (1972)
3. Buchthal, F., Svensmark, O.: Aspects of the pharmacology of phenytoin (Dilantin®) and phenobarbital relevant to their dosage in the treatment of epilepsy. Epilepsia1, 373?384 (1959/60)
4. Chang, T., Glazko, A. J.: Quantitative assay of 5.5-diphenylhydantoin (Dilantin®) and 5-(p-hydroxyphenyl)-5-phenylhydantoin by gas-liquid chromatography. J. Lab. clin. Med.75, 145?155 (1970)
5. Dörrschedit, E.: Über die Serumkonzentration von Diphenylhydantoin in der Epilepsiebehandlung. Dissertation, Universität Heidelberg 1973
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献